An enzyme-linked immunoadsorbent assay for human pituitary glycoprotein free α-subunit: evaluation and initial experience in patients with pituitary disease

in Journal of Endocrinology
Authors:
V. N. Anyaoku
Search for other papers by V. N. Anyaoku in
Current site
Google Scholar
PubMed
Close
,
D. F. Wood
Search for other papers by D. F. Wood in
Current site
Google Scholar
PubMed
Close
,
R. Pavlou
Search for other papers by R. Pavlou in
Current site
Google Scholar
PubMed
Close
,
P. Williams
Search for other papers by P. Williams in
Current site
Google Scholar
PubMed
Close
,
K. Tan
Search for other papers by K. Tan in
Current site
Google Scholar
PubMed
Close
,
S. Fidler
Search for other papers by S. Fidler in
Current site
Google Scholar
PubMed
Close
, and
D. G. Johnston
Search for other papers by D. G. Johnston in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

ABSTRACT

An enzyme-linked immunoadsorbent assay (ELISA) for measuring human pituitary glycoprotein free α-subunit is described. Pituitary tumours may secrete glycoprotein hormones, their free subunits (α, β) or a combination of these. Non-functioning adenomas often secrete free α-subunit. Assays for free α-subunit have previously used radioimmunoassay or immunoradiometric principles. Some of these methods are time-consuming and lack specificity and sensitivity. In order to overcome these problems, we have developed a two-site ELISA for α-subunit which uses a monoclonal antibody to α-subunit as the capture antibody to provide greater specificity. An affinity-purified polyclonal anti α-subunit conjugated to alkaline phosphatase was the signal antibody. Detection and quantification were based on phenolphthalein monophosphate conversion to phenolphthalein. The ELISA specifically measured glycoprotein free α-subunit in serum or plasma, discriminating between α-subunit and the intact glycoprotein hormones. The assay can be completed in 4 h. The assay sensitivity was 0·03 μg/l, and a normal range of 0·05 to 0·22 μg/l was established. In a retrospective study, elevated circulating glycoprotein α-subunit was detected in 22% of patients with non-functioning pituitary tumours previously treated with surgery and/or radiotherapy.

Journal of Endocrinology (1993) 136, 511–516

 

  • Collapse
  • Expand